Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-029950
Filing Date
2025-03-31
Accepted
2025-03-31 16:53:12
Documents
6
Effectiveness Date
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2510621d1_s8.htm S-8 34300
2 EXHIBIT 5.1 tm2510621d1_ex5-1.htm EX-5.1 9070
3 EXHIBIT 23.2 tm2510621d1_ex23-2.htm EX-23.2 1855
4 EX-FILING FEES tm2510621d1_ex-filingfees.htm EX-FILING FEES 11901
5 GRAPHIC tm2510621d1_ex5-1img001.jpg GRAPHIC 4600
6 GRAPHIC tm2510621d1_ex5-1img002.jpg GRAPHIC 34990
  Complete submission text file 0001104659-25-029950.txt   113238
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286274 | Film No.: 25794420
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)